RICHC
PFE icon

Renaissance Investment Consultants Holding Company’s Pfizer PFE Stock Holding History

Renaissance Investment Consultants Holding Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,779
Closed -$325K – 87
2020
Q2 		$325K Buy
8,779
+52
+0.6% +$1.77K 0.36% 56
2020
Q1 		$270K Buy
8,727
+55
+0.6% +$1.87K 0.38% 62
2019
Q4 		$320K Buy
+8,672
New +$309K 0.36% 67

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Renaissance Investment Consultants Holding Company's PFE Position: Q3 2020 in Review

Renaissance Investment Consultants Holding Company sold out of Pfizer (PFE) in Q3 2020, closing a stake of 8,779 shares — an estimated $325K sold.

Renaissance Investment Consultants Holding Company first reported a position in PFE in Q4 2019 and held it in 3 quarters. The position peaked at $325K in Q2 2020. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Renaissance Investment Consultants Holding Company reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
  • Renaissance Investment Consultants Holding Company sold 8,779 Pfizer shares in Q3 2020, an estimated $325K.
  • Renaissance Investment Consultants Holding Company first reported a position in Pfizer in Q4 2019 and held it in 3 quarters.
  • Renaissance Investment Consultants Holding Company's Pfizer position peaked at $325K in Q2 2020.
  • 2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Renaissance Investment Consultants Holding Company's 13F filing for Q3 2020, filed 6 Nov 2020.